Middle East and Africa Radiopharmaceuticals Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others)

No. of Pages: 142    |    Report Code: TIPRE00025880    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East and Africa Radiopharmaceuticals Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Middle East and Africa Radiopharmaceuticals Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Middle East and Africa Radiopharmaceuticals Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Prevalence of Chronic Diseases
  • 5.1.2 Growing Number of Clinical Trials in Targeted Therapy
5.2 Market Opportunities
  • 5.2.1 High Growth Potential in Developing Countries
5.3 Future Trends
  • 5.3.1 Short Shelf-Life of Radiopharmaceuticals
5.4 Impact of Drivers and Restraints

6. Middle East and Africa Radiopharmaceuticals Market Regional Analysis

6.1 Middle East and Africa Radiopharmaceuticals Market Overview
6.2 Middle East and Africa Radiopharmaceuticals Market Revenue 2019-2028 (US$ Million)
6.3 Middle East and Africa Radiopharmaceuticals Market Forecast Analysis

7. Middle East and Africa Radiopharmaceuticals Market Analysis – by Type

7.1 Diagnostic Nuclear Medicine
  • 7.1.1 Overview
  • 7.1.2 Diagnostic Nuclear Medicine: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Therapeutic Nuclear Medicine
  • 7.2.1 Overview
  • 7.2.2 Therapeutic Nuclear Medicine: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East and Africa Radiopharmaceuticals Market Analysis – by Application

8.1 Oncology
  • 8.1.1 Overview
  • 8.1.2 Oncology: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Cardiology
  • 8.2.1 Overview
  • 8.2.2 Cardiology: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Neurology
  • 8.3.1 Overview
  • 8.3.2 Neurology: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East and Africa Radiopharmaceuticals Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Neurology: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Imaging Centers
  • 9.2.1 Overview
  • 9.2.2 Neurology: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Academic and Research Centers
  • 9.3.1 Overview
  • 9.3.2 Neurology: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East and Africa Radiopharmaceuticals Market – Middle East and Africa Analysis

10.1 Middle East and Africa
  • 10.1.1 Middle East and Africa Radiopharmaceuticals Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 South Africa: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 South Africa: Middle East and Africa Radiopharmaceuticals Market Breakdown, by Type
    • 10.1.1.1.2 South Africa: Middle East and Africa Radiopharmaceuticals Market Breakdown, by Application
    • 10.1.1.1.3 South Africa: Middle East and Africa Radiopharmaceuticals Market Breakdown, by End User
  • 10.1.1.2 Saudi Arabia: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Saudi Arabia: Middle East and Africa Radiopharmaceuticals Market Breakdown, by Type
    • 10.1.1.2.2 Saudi Arabia: Middle East and Africa Radiopharmaceuticals Market Breakdown, by Application
    • 10.1.1.2.3 Saudi Arabia: Middle East and Africa Radiopharmaceuticals Market Breakdown, by End User
  • 10.1.1.3 UAE: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 UAE: Middle East and Africa Radiopharmaceuticals Market Breakdown, by Type
    • 10.1.1.3.2 UAE: Middle East and Africa Radiopharmaceuticals Market Breakdown, by Application
    • 10.1.1.3.3 UAE: Middle East and Africa Radiopharmaceuticals Market Breakdown, by End User
  • 10.1.1.4 Rest of Middle East and Africa: Middle East and Africa Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Radiopharmaceuticals Market Breakdown, by Type
    • 10.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Radiopharmaceuticals Market Breakdown, by Application
    • 10.1.1.4.3 Rest of Middle East and Africa: Middle East and Africa Radiopharmaceuticals Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Middle East and Africa Radiopharmaceuticals Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Advanced Accelerator Applications
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bayer AG
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Bracco Imaging S.p.A
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Cardinal Health Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Curium
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 ECZACIBAI MONROL NUCLEAR PRODUCTS CO.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 GENERAL ELECTRIC
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Nordion
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 NTP RADIOISOTOPES
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - M Market

  1. Advanced Accelerator Applications
  2. Bayer AG
  3. Bracco Imaging S.p.A
  4. Cardinal Health Inc
  5. Curium
  6. ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.
  7. GENERAL ELECTRIC
  8. Nordion
  9. NTP RADIOISOTOPES     
middle-east-and-africa-radiopharmaceuticals-market